The Patent Finder

Sevion Therapeutics, Inc.

Also on record
Records under this name other than patents Sevion Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Sevion Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,232,455Polynucleotides encoding canola DHS and antisense polynucleotides thereof
Formerly held
Term ended
Term ended Jan 25, 2022 · USPTO record
Term endedTerm ended Jan 25, 2022USPTO record
US 7,663,028Method of Increasing Seed Yield and Growth EIF-5A
Formerly held
Term ended
Term ended Apr 27, 2020 · Medium confidence
Term endedTerm ended Apr 27, 2020Medium confidence
US 7,358,418Isoforms of EIF-5A: Senescence-Induced ELF5A; Wounding-Induced EIF-5A; Growth EIF-5A; and DHS
Formerly held
Term ended
Term ended Jan 17, 2020 · Medium confidence
Term endedTerm ended Jan 17, 2020Medium confidence
US 7,087,419DNA Encoding a Plant Lipase, Transgenic Plants and a Method for Controlling Senescence in Plants
Formerly held
Lapsed on the fee record
Ended Aug 8, 2018 · Medium confidence
Lapsed on the fee recordEnded Aug 8, 2018Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited